Quality assured and validated tests

Noviral has since the outbreak of Covid-19 made it its mission to support the fight against the pandemic. We do so by offering testing solutions that are scalable, reliable and easy to use. Noviral’s product portfolio consists of two qualitative tests – a rapid antigen test screening for ongoing infection and a rapid antibody test detecting previous infection. These have been used by more than 500,000 patients in 20+ markets.

The tests distributed by Noviral have the common denominator of being rapid tests suitable for implementation in any country, corporation or community. We are happy to advise how the tests can be implemented in any setting and how to achieve the most value from doing so. Please contact us for more information.

Learn more about the differences between antibody and antigen testing here

Contact Us

Covid-19 Rapid Antigen test

Noviral’s antigen test is a point of care test identifying infection carries within 10-15 minutes. The test is taken through a nasopharyngeal swab and is thanks to its ease of use implementable in any setting. An antigen test should be taken within the first days after the onset of symptoms for best results. The CE certified test offered by Noviral is reliable, accessible and can be helpful in breaking infection chains. It is valuable to use in settings that could benefit from immediate results why it has been widely implemented as part of screening programmes all over Europe. 

  • Identifies infection carriers with high precision 
  • CE certified
  • Sensitivity is 96.72% and specificity is 99.22% compared to gold standard
  • The antigen test is taken through a nasopharyngeal swab and is very easy to use

Read more about the test here


Covid-19 Rapid Ag Saliva Test

COVID-19 Antigen Rapid Test Cassette (Saliva) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Saliva from individuals suspected of COVID-19 infection. The test provides results within 10 minutes and is thanks to its ease of use a great substitute to PCR and nasopharyngeal swab assays. 

  • Identifies infection carriers with high precision
  • CE Certified
  • Sensitivity 99.33%, Specificity 98.1% 
  • The antigen test is taken through a saliva sample and does not require any specialized equipment or personnel

 


Covid-19 Rapid Antibody test


SARS-CoV-2 / Influenza Combo Assay

Noviral offers a combo assay for a fast and simultaneous qualitative detection of SARS-CoV-2 and Influenza A & B. The rapid test aids patient treatment decisions quickly and provides test results within 15 minutes. 

  • CE Certified 
  • Influenza A specificity: 96.4% sensitivity: 92.6% (nasopharyngeal swab)
  • Influenza B specificity: 95.8% sensitivity: 90.0% (nasopharyngeal swab)
  • SARS-CoV-2 specificity: 99.22% sensitivity: 96.72% (nasopharyngeal swab)
  • The test consist of a double test cassette where specimen is tested for both influenza and SARS-CoV-2 virus simultaneously 

FAQ

It is a combined IgM / IgG antibody test for Covid-19 used to qualitatively detect the presence of coronavirus IgG and IgM antibodies in human serum, plasma or whole blood in vitro.

The test is performed in five simple steps. First, a stick is taken in the finger. The blood is drawn in with a disposable pipette and then added to the center box (S). The buffer solution is added to the round well at the bottom (B). The answer should be read within 15 minutes.

Unlike laboratory-based tests, test results can be read within 15 minutes.

The test shows whether a person has undergone a Covid-19 infection and thus developed antibodies. The test results are collected and compiled in DigiTrack, which provides a good basis for determining how employees should be organized and coordinated in the best way, in order to reduce the risk of new spread of infection.

According to current guidelines from the Public Health Authority, antibody tests for Covid-19 are not subject to reporting obligations for the disease according to the Infection Protection Act.

Yes, the test is CE marked. CE marking is a product marking in the EU and the European Economic Area (EEA). The letters CE are the abbreviation for Conformité Européenne (‘in accordance with EC directives’). A product with CE marking may be sold in the EEA area.
The rapid test has also, since May 2020, received EUA approval by the FDA (Food and Drug Administration), the US counterpart to the Swedish Medicines Agency.